Frontotemporal Dementia
114
23
36
53
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
11 trials with published results (10%)
Research Maturity
53 completed trials (46% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.6%
3 terminated out of 114 trials
94.6%
+8.1% vs benchmark
5%
6 trials in Phase 3/4
21%
11 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 53 completed trials
Clinical Trials (114)
Nabilone for Agitation in Frontotemporal Dementia
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
MSC-Exosome Therapy for Frontotemporal Dementia
Neurologic Stem Cell Treatment Study
Imaging of Brain Amyloid Plaques in the Aging Population
Neurofilament Surveillance Project (NSP)
TRIAL READY (Clinical Trial Readiness)
Phenotype, Genotype and Biomarkers 2
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated.
A Study of Caregiver Connections Via Technology in Dementia
GENetic Fronto Temporal Dementia Initiative in Lille
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
A Study of PBFT02 in Participants With FTD and Mutations in the Granulin Precursor (GRN) or C9ORF72 Genes
Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
Epidemiological Study in FRONtoTemporal Dementia